# 弹性体输注泵市场

> 弹性体输注泵市场研究报告按泵类型（容积输注泵、注射器输注泵、弹性体输注泵）、按应用（肿瘤学、麻醉、疼痛管理、化疗、儿科护理）、按最终用户（医院、居家护理、门诊手术中心、护理院）、按作用机制（持续输注、间歇性输注）、按产品型号（便携式输注泵、固定式输注泵）以及按地区（北美、欧洲、南美、亚太、中东和非洲） - 预测到2035年

- **Forecast Period:** 2025 - 2035
- **CAGR:** 4.63%
- **2024:** $ 3.28 Billion
- **2025:** $ 3.43 Billion
- **2035:** $ 5.39 Billion
- **Key Players:** Baxter International Inc (US), B. Braun Melsungen AG (DE), Fresenius Kabi AG (DE), Smiths Medical (US), Moog Inc (US), Halyard Health (US), ICU Medical Inc (US), Terumo Corporation (JP), Medtronicplc (IE)

**Report ID:** MRFR/HC/30541-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** August 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/elastomeric-infusion-pump-market-32334

---

## Market Summary

## **Elastomeric Infusion Pump Market Overview**

As per MRFR analysis, the Elastomeric Infusion Pump Market Size was estimated at 3.28 (USD Billion) in 2024. The Elastomeric Infusion Pump Market Industry is expected to grow from 3.43 (USD Billion) in 2025 to 5.15 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 4.63% during the forecast period (2025 - 2034).

### **Key Elastomeric Infusion Pump Market Trends Highlighted**

The Elastomeric Infusion Pump Market is driven by several key factors that enhance its prominence in the healthcare sector. One major driver is the increasing demand for outpatient care solutions, as healthcare systems focus on providing advanced treatments outside of hospital settings. Elastomeric infusion pumps are recognized for their portability, ease of use, and cost-effectiveness, which contribute significantly to their growing adoption among patients and healthcare providers alike.

Additionally, the rise in chronic diseases requiring long-term therapy, including cancer and pain management, further propels the need for reliable infusion systems that offer continuous medication delivery. Opportunities within the market are abundant, particularly as technological advancements pave the way for enhanced functionalities in infusion pumps. Innovations in drug delivery systems, including smart technologies and the integration of telehealth applications, present a compelling avenue for market expansion.

Manufacturers are increasingly focused on developing elastomeric infusion pumps with improved accuracy, safety features, and user-friendly designs, catering to both patient and healthcare provider needs. In recent times, there has been a noticeable trend towards the implementation of customized therapy options, which align with personalized medicine principles. This trend emphasizes the importance of scaling infusion pumps to accommodate diverse patient requirements and medication regimens.

Furthermore, the growing emphasis on infection control and the need for sterile, single-use devices have reinforced the market’s momentum. Overall, the landscape of the elastomeric infusion pump market is evolving rapidly, driven by innovation, increased patient needs, and the continuous push for improved healthcare delivery.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Elastomeric Infusion Pump Market Drivers**

### **Increasing Demand for Home Healthcare Solutions**

The Elastomeric Infusion Pump Market Industry is experiencing significant growth driven by the increasing demand for home healthcare solutions. As healthcare systems evolve, there is a trend towards decentralization of healthcare services, leading to a rise in home care management. Patients are now being treated for chronic conditions at home rather than in hospitals or clinics, a shift that has been accelerated by recent health emergencies.

This change compels healthcare providers to seek reliable, portable, and user-friendly infusion devices that can be used safely outside traditional clinical settings. As a result, elastomeric infusion pumps, known for their ease of use and efficient drug delivery mechanisms, are gaining preference among healthcare providers. The ability of these devices to provide accurate dosing over extended periods without the need for external power sources makes them particularly suitable for managing conditions such as pain management, antibiotic delivery, and chemotherapy.

Furthermore, the growing elderly population, who often require long-term treatment at home, is fueling the demand for elastomeric infusion pumps. As the market continues to expand, manufacturers are focusing on innovation and technology enhancements to improve usability and expand functionality, making these devices an integral part of home healthcare solutions and contributing to the growth of the Elastomeric Infusion Pump Market.

### **Technological Advancements in Infusion Devices**

Technological advancements play a crucial role in the expansion of the Elastomeric Infusion Pump Market Industry. Continuous research and development have led to the introduction of sophisticated infusion pumps that offer improved safety features, real-time monitoring, and enhanced user interfaces. These technological innovations help in reducing medication errors and ensuring precise drug delivery. The integration of smart technology into elastomeric infusion pumps facilitates better patient care, allowing healthcare professionals to monitor patient infusion remotely and adjust treatment protocols as necessary.

This level of innovation not only boosts operational efficiency but also enhances patient outcomes, which is increasingly important in today's healthcare landscape.

### **Rising Prevalence of Chronic Diseases**

The rising prevalence of chronic diseases is accelerating the growth of the Elastomeric Infusion Pump Market Industry. Conditions such as diabetes, cancer, and cardiovascular diseases necessitate ongoing treatment and management, often requiring regular infusion therapies. As the population ages and lifestyle-related diseases become more prevalent, the demand for effective and reliable infusion devices has surged significantly. Elastomeric infusion pumps provide a valuable solution for patients requiring long-term medication regimens, making them a critical component in chronic disease management strategies implemented by healthcare providers worldwide.

## **Elastomeric Infusion Pump Market Segment Insights**

### **Elastomeric Infusion Pump Market Pump Type Insights**

The Elastomeric Infusion Pump Market has shown robust growth, specifically within the Pump Type segment. In 2023, the overall market is valued at 3.0 USD Billion, providing a strong foundation for its expansion. The segmentation of the market into various pump types includes Volumetric Infusion Pumps, Syringe Infusion Pumps, and Elastomeric Infusion Pumps, each contributing significantly to the overall figures. Volumetric Infusion Pumps lead the market with a valuation of 1.5 USD Billion in 2023, accounting for a majority holding in this segment.

Their advanced precision in administering medications makes them a critical choice for healthcare facilities, reflecting trends toward enhanced patient safety and treatment efficacy. Syringe Infusion Pumps follow closely, valued at 1.0 USD Billion in the same year, and are particularly significant for applications requiring lower volume infusion rates, thus facilitating personalized medication delivery. These pumps have gained popularity due to their compact design and usability in various clinical settings, making them an important part of the ecosystem.

Additionally, Elastomeric Infusion Pumps, though valued at 0.5 USD Billion in 2023, contribute to the market by offering a cost-effective solution for continuous medication delivery, which aligns well with the growing demand for home healthcare systems and outpatient therapies. The overall growth of the Elastomeric Infusion Pump Market is driven by increasing chronic disease prevalence and technological advancements that enhance pump efficiency, making these instruments essential in modern healthcare. As important elements of their respective market categories, each pump type's valuation and significance reflect a greater trend toward optimizing patient care and treatment methodologies.

With the combined relevance of Volumetric and Syringe Infusion Pumps dominating the market landscape, the infusion pump sector is set to undergo notable transformations bolstered by ongoing innovation and increasing healthcare investments. Consequently, the Elastomeric Infusion Pump Market segmentation not only illustrates current market dynamics but also highlights opportunities for further growth and improvement in the field of infusion therapies.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Elastomeric Infusion Pump Market Application Insights**

The Elastomeric Infusion Pump Market, valued at 3.0 USD Billion in 2023, showcases significant growth potential through various applications, reflecting a robust market growth trajectory. Within this segment, the applications are diverse, covering critical areas including Oncology, Anesthesia, Pain Management, Chemotherapy, and Pediatric Care, each playing a pivotal role in care delivery. Oncology remains a crucial sector, driven by the rising incidence of cancer, leading to increased demand for efficient drug administration. Similarly, Anesthesia and Pain Management applications are vital, supporting a growing number of surgical procedures and chronic pain treatments.

**[Chemotherapy](../../../reports/chemotherapy-market-5791)** applications are witnessing notable advancements, necessitating reliable infusion methods for cancer therapies. Pediatric Care is also a significant focus, addressing the unique infusion needs of younger patients, contributing to the overall market diversification and growth. Overall, the Elastomeric Infusion Pump Market demonstrates comprehensive segmentation, offering insights into revenue generation while accommodating the various demands of healthcare settings and enhancing patient outcomes.

### **Elastomeric Infusion Pump Market End User Insights**

The Elastomeric Infusion Pump Market holds a significant status among end users, which include Hospitals, Home Care Settings, Ambulatory Surgical Centers, and Nursing Homes. In 2023, the overall market is valued at 3.0 USD Billion, reflecting its importance in enhancing patient care and outcomes. Hospitals dominate this segment due to their high patient volumes and extensive use of advanced medical technologies. Meanwhile, Home Care Settings are gaining traction as more patients prefer receiving care in the comfort of their own homes, driving demand for user-friendly infusion devices.

Ambulatory Surgical Centers are also noteworthy, providing efficient surgical care where elastomeric infusion pumps streamline medication administration. Nursing Homes contribute significantly by catering to the growing elderly population needing ongoing medical support, leveraging these pumps for effective treatment delivery. The rising demand for minimally invasive procedures and home healthcare solutions further underscores the potential for market growth within these end user categories, revealing opportunities for innovation and expansion in the Elastomeric Infusion Pump Market industry.

### **Elastomeric Infusion Pump Market Mechanism of Action Insights**

The Elastomeric Infusion Pump Market, valued at 3.0 USD Billion in 2023, is segmented by Mechanism of Action into Continuous Infusion and Intermittent Infusion methods. Continuous Infusion is recognized for its capability to provide a steady medication dosage, thus enhancing patient compliance and treatment efficacy in varied medical situations. Meanwhile, Intermittent Infusion is significant in clinical settings requiring flexible dosing regimens, allowing healthcare providers to administer medications at set intervals, which is particularly beneficial in outpatient care.

The demand for elastomeric infusion pumps is driven by an increasing preference for home healthcare solutions and enhanced drug delivery techniques characterized by precision and effectiveness. Additionally, the evolving healthcare landscape and technological advancements in infusion systems contribute to the market growth. However, challenges such as regulatory compliance and device configuration complexities may hinder market penetration. Nevertheless, significant opportunities arise from rising chronic diseases and an escalating geriatric population requiring long-term treatments, fostering the need for efficient infusion systems.

Overall, the Elastomeric Infusion Pump Market data highlights a robust growth trajectory supported by ongoing innovations and favorable trends within the industry.

### **Elastomeric Infusion Pump Market Product Model Insights**

In 2023, the Elastomeric Infusion Pump Market is valued at 3.0 billion USD, showcasing significant growth potential driven by advancements in medical technology and rising demand for efficient drug delivery solutions. The market is characterized by two main types Portable Infusion Pumps and Stationary Infusion Pumps. Portable Infusion Pumps hold a major share in the market as their design allows for mobility, catering to patients requiring home care or outpatient services. The ability to provide flexible treatment options, such as pain management and cancer therapy, makes these devices invaluable in modern healthcare settings.

On the other hand, Stationary Infusion Pumps are critical in hospital environments where precision and continuous infusion are necessary for critically ill patients. The Elastomeric Infusion Pump Market statistics reflect a market growth driven by the increasing prevalence of chronic diseases and the rising geriatric population seeking effective treatment. Both segments play a key role in healthcare, with their functionalities and features catering to specific patient needs while addressing challenges in drug delivery management. The continuous evolution in technology and increasing preference for minimally invasive procedures present numerous opportunities for growth in the Elastomeric Infusion Pump Market.

### **Elastomeric Infusion Pump Market Regional Insights**

The Elastomeric Infusion Pump Market demonstrates a diverse regional segmentation, with North America leading in valuation at 1.2 USD Billion in 2023, expected to grow to 1.8 USD Billion by 2032, thus holding a majority share due to advanced healthcare infrastructure and high adoption rates of innovative medical technologies. Europe follows closely with a valuation of 0.9 USD Billion in 2023, anticipated to rise to 1.3 USD Billion, reflecting significant market growth driven by increasing investments in healthcare and research.

Asia Pacific is gaining traction, with a market value of 0.7 USD Billion in 2023 and projected to reach 1.1 USD Billion by 2032, indicating the region’s emerging importance due to rapid healthcare advancements and growing patient populations.

In contrast, the Middle East and Africa market remains relatively small, valued at 0.1 USD Billion in both 2023 and 2032, showcasing developmental challenges and a slower adoption rate of infusion technologies. South America holds a minimal yet evolving position with a valuation of 0.1 USD Billion in 2023, growing to 0.2 USD Billion by 2032, reflecting gradual improvements in healthcare access and economic conditions. These dynamics illustrate how the Elastomeric Infusion Pump Market revenue and segmentation are shaped by regional healthcare systems and market readiness.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Elastomeric Infusion Pump Market Key Players And Competitive Insights**

The Elastomeric Infusion Pump Market represents a vital segment within the healthcare industry, particularly in the context of medication delivery systems. This market is characterized by its competitive landscape, marked by a variety of players striving to innovate and enhance the efficiency of drug delivery. With advancements in technology and rising demand for effective pain management and chronic disease management solutions, stakeholders are constantly exploring avenues to enhance their market penetration and product offerings. The infusion pumps are designed to ensure precise delivery of medication, rendering them essential in settings such as hospitals and home care.

Key players are focusing on research and development, strategic partnerships, and acquisitions to leverage market opportunities and stay ahead in this evolving landscape.

Moog Inc. is a significant player in the Elastomeric Infusion Pump Market, recognized for its commitment to providing high-quality and reliable infusion technologies. The company integrates innovation with patient needs, focusing on developing elastomeric infusion pumps that are both user-friendly and efficient. One of its key strengths lies in its robust product portfolio, which caters to a wide range of therapeutic areas, providing solutions for both acute and chronic conditions. Furthermore, Moog Inc. benefits from a strong reputation for quality and reliability, which resonates well with healthcare professionals and patients alike.

The company’s presence in numerous international markets also enables it to adapt its strategies and products to meet diverse healthcare requirements across different regions, bolstering its competitive advantage in the sector.

Medtronic is a leading player in the Elastomeric Infusion Pump Market, known for its innovative solutions and extensive experience in medical technology. The company has established a strong niche in the infusion device sector through a combination of advanced technology and comprehensive product offerings designed to enhance patient care. Medtronic primarily focuses on delivering solutions that improve operational efficiencies within healthcare settings, ensuring timely and accurate drug delivery.

Its competitive edge is largely attributed to its research capabilities, enabling the development of cutting-edge infusion pumps that incorporate user-friendly features aimed at reducing the burden on medical staff while ensuring patient safety.

Additionally, the company's reach and established distribution channels facilitate effective market penetration, allowing Medtronic to maintain a significant position in the elastomeric infusion pump market.

### **Key Companies in the Elastomeric Infusion Pump Market Include**

- Moog Inc.
- [**Medtronic**](https://www.medtronic.com/in-en/healthcare-professionals/products.html)
- ICU Medical
- Vygon
- Fresenius Kabi
- Medline Industries
- Smiths Medical
- Halyard Health
- Zyno Medical
- Terumo Corporation
- Robilex
- NIPRO Corporation
- Baxter International
- BD
- KORU Medical Systems

## Elastomeric Infusion Pump Industry Developments

- **Q1 2024: Baxter Launches Next-Generation Elastomeric Infusion Pump in Europe** Baxter International announced the commercial launch of its new elastomeric infusion pump, designed for improved accuracy and patient comfort, across select European markets following CE mark approval.
- **Q2 2024: Fresenius Kabi Receives FDA 510(k) Clearance for Updated Elastomeric Infusion Pump** Fresenius Kabi announced it has received FDA 510(k) clearance for its latest elastomeric infusion pump, enabling expanded use in outpatient and home care settings in the United States.
- **Q2 2024: Leventon Expands Manufacturing Capacity for Elastomeric Infusion Pumps in Spain** Leventon S.A.U. inaugurated a new production line at its Barcelona facility to meet growing demand for elastomeric infusion pumps in Europe and Latin America.
- **Q3 2024: B. Braun Launches Easypump II Elastomeric Infusion Pump in Asia-Pacific** B. Braun announced the launch of its Easypump II elastomeric infusion pump in key Asia-Pacific markets, targeting post-operative pain management and chemotherapy applications.
- **Q3 2024: Ambu A/S Appoints New Head of Infusion Devices Division** Ambu A/S named Dr. Maria Jensen as the new Head of its Infusion Devices Division, overseeing the global strategy for elastomeric infusion pump products.
- **Q4 2024: Terumo Corporation Announces Strategic Partnership with Japanese Hospital Group for Elastomeric Infusion Pump Supply** Terumo signed a multi-year supply agreement with a leading Japanese hospital group to provide elastomeric infusion pumps for oncology and pain management therapies.
- **Q4 2024: Smiths Medical Receives Health Canada Approval for CADD®-Solis Elastomeric Infusion Pump** Smiths Medical announced Health Canada approval for its CADD®-Solis elastomeric infusion pump, enabling commercial distribution across Canada.
- **Q1 2025: Baxter Signs Distribution Agreement with Major U.S. Home Infusion Provider** Baxter entered into a distribution agreement with a leading U.S. home infusion provider to supply its elastomeric infusion pumps for chronic disease management.
- **Q1 2025: Vygon Group Launches New Elastomeric Infusion Pump for Pediatric Use** Vygon Group introduced a pediatric-specific elastomeric infusion pump, designed for precise low-volume drug delivery, in European markets.
- **Q2 2025: Nipro Corporation Opens New Elastomeric Infusion Pump Manufacturing Facility in Vietnam** Nipro Corporation opened a new manufacturing facility in Vietnam dedicated to elastomeric infusion pumps, aiming to strengthen its supply chain in Asia.
- **Q2 2025: Fresenius Kabi Partners with U.S. Oncology Network for Elastomeric Infusion Pump Deployment** Fresenius Kabi announced a partnership with the U.S. Oncology Network to deploy its elastomeric infusion pumps for outpatient chemotherapy treatments.
- **Q2 2025: B. Braun Receives CE Mark for Next-Generation Elastomeric Infusion Pump** B. Braun received CE mark approval for its next-generation elastomeric infusion pump, enabling expanded sales across the European Union.

## **Elastomeric Infusion Pump Market Segmentation Insights**

### **Elastomeric Infusion Pump Market Pump Type Outlook**

- Volumetric Infusion Pumps
- Syringe Infusion Pumps
- Elastomeric Infusion Pumps

### **Elastomeric Infusion Pump Market Application Outlook**

- Oncology
- Anesthesia
- Pain Management
- Chemotherapy
- Pediatric Care

### **Elastomeric Infusion Pump Market End User Outlook**

- Hospitals
- Home Care Settings
- Ambulatory Surgical Centers
- Nursing Homes

### **Elastomeric Infusion Pump Market Mechanism of Action Outlook**

- Continuous Infusion
- Intermittent Infusion

### **Elastomeric Infusion Pump Market Product Model Outlook**

- Portable Infusion Pumps
- Stationary Infusion Pumps

### **Elastomeric Infusion Pump Market Regional Outlook**

- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa

## Market Drivers

### 慢性疾病的日益普遍

弹性体输注泵市场受到慢性疾病（如糖尿病、癌症和心血管疾病）日益普遍的显著影响。这些疾病通常需要长期的药物管理，这就需要有效的输注系统。慢性疾病病例的增加促使医疗服务提供者寻求可靠和高效的药物输送解决方案。市场分析表明，弹性体输注泵的需求将继续增长，因为它们为管理复杂的治疗方案提供了实用的解决方案。此外，老龄化人口可能会加剧这一趋势，因为老年人更容易患上慢性疾病。因此，弹性体输注泵市场在应对这些人口变化时，预计将实现显著增长。

### 输液系统的技术进步

弹性体输注泵市场正在经历技术进步的激增，这些进步提高了输注系统的效率和可靠性。集成了剂量计算和实时监测软件的智能泵等创新正变得越来越普遍。这些进步不仅改善了患者的治疗效果，还简化了医疗操作。预计在未来几年内，输注泵市场将以约8%的复合年增长率增长，这一增长受到这些技术改进的推动。此外，无线连接的集成使得数据管理和患者追踪更为有效，这在现代医疗环境中至关重要。随着医疗提供者寻求采用更复杂的解决方案，对先进的弹性体输注泵的需求可能会增加，从而推动市场向前发展。

### 关注患者安全和护理质量

弹性体输注泵市场越来越重视患者安全和护理质量。医疗服务提供者面临着不断减少用药错误和提高患者结果的压力。弹性体输注泵旨在提供精确的剂量，从而降低过量或不足输注的风险。这种对安全的关注反映在这些设备在各种医疗环境中的日益普及。根据最近的研究，弹性体泵的实施显著减少了不良药物事件，这对医疗专业人员来说是一个关键问题。随着监管机构继续强调患者安全的重要性，对可靠输注系统的需求预计将上升，进一步推动弹性体输注泵市场的发展。

### 弹性体输注泵的成本效益

弹性体输注泵市场受益于弹性体输注泵相较于传统输注系统的成本效益。这些设备通常更实惠，维护需求较少，使其成为面临预算限制的医疗机构的一个有吸引力的选择。与弹性体泵相关的较低运营成本可以为医院和诊所带来显著的节省，这在医疗成本上升的时代尤为吸引人。此外，易于使用和减少对专业培训的需求进一步增强了它们的吸引力。随着医疗提供者努力优化资源，同时保持高质量的护理，弹性体输注泵的成本效益可能会推动其采用，从而促进市场的增长。

### 家庭医疗解决方案的需求上升

弹性体输注泵市场正见证家庭医疗解决方案需求的显著增长。随着患者越来越倾向于在家中接受护理，对便携且用户友好的输注设备的需求也在上升。弹性体输注泵以其易用性和可靠性而闻名，非常适合家庭医疗应用。市场数据显示，家庭医疗细分市场预计将显著增长，弹性体泵在这一转变中发挥着关键作用。这一转变不仅减轻了医疗机构的负担，还提高了患者的满意度和对治疗方案的遵循。因此，向家庭医疗的上升趋势可能会推动弹性体输注泵市场的增长，因为越来越多的患者选择这些便捷的解决方案。

## Future Outlook

弹性体输注泵市场预计将在2024年至2035年间以4.63%的年均增长率增长，推动因素包括技术进步、慢性疾病患病率上升以及对居家医疗解决方案的需求。

**New opportunities:**

- 进入新兴市场，提供量身定制的产品。 开发具有集成监测功能的智能弹性泵。 与远程医疗平台建立合作关系，以提供远程患者管理解决方案。

到2035年，市场预计将实现强劲增长，成为医疗服务的关键参与者。

## Segment Insights

### 按泵类型：体积输注泵（最大）与注射器输注泵（增长最快）

在弹性体输注泵市场中，市场份额分布由容积输注泵主导，因其在提供精确药物剂量方面的多功能性和高效性而成为最大的细分市场。注射器输注泵紧随其后，随着医疗机构寻求更紧凑和移动的患者护理选项，市场采用率显著增加。该细分市场的增长趋势表明，注射器输注泵的需求正在上升，被认为是增长最快的细分市场，推动因素是对门诊环境中个性化药物输送的日益需求。技术进步、增强的安全特性以及慢性疾病的日益普遍等因素进一步推动了市场上容积和注射器输注泵的采用。

体积输注泵（主导）与注射器输注泵（新兴）

体积输液泵因其能够以受控速率准确输送液体而备受推崇，使其在需要大量和特定剂量的医院环境中占据主导地位。其强大的功能支持广泛的治疗，因此在市场中占有重要份额。相比之下，注射泵作为一种新兴的替代方案，特别是在家庭医疗和门诊场景中，由于其便携性和易用性而受到青睐。虽然它们的输送量可能不及体积泵，但它们与技术和远程医疗功能的日益整合支持了其快速采用，表明偏好向更以患者为中心的解决方案转变。

### 按应用：肿瘤学（最大）与麻醉学（增长最快）

在弹性体输注泵市场中，肿瘤学应用占据最大份额，主要受癌症发病率上升和对精确药物管理需求增加的推动。麻醉应用虽然目前较小，但随着医疗服务提供者寻求在外科手术中高效有效的药物输送方法，正在迅速获得市场份额。这些细分市场共同展示了一个竞争激烈的市场格局，其中专业应用对市场动态至关重要。增长趋势表明，疼痛管理和化疗应用也在稳步扩展，受到患者意识提高和输注技术进步的推动。儿科护理虽然是一个小众细分市场，但由于对年轻人群体个性化医疗的关注增加，预计将经历显著增长。总体而言，随着医疗优先事项向专业和有效的治疗管理转变，市场显示出强大的潜力。

肿瘤学（主导）与儿科护理（新兴）

肿瘤学在弹性输注泵市场中占据主导地位，其关键作用在于施用复杂的化疗方案。弹性泵专注于减少副作用并提高患者舒适度，提供可靠的药物输送，这在肿瘤治疗中至关重要。儿科护理虽然是一个新兴领域，但随着医疗系统越来越认识到儿童独特的用药需求，其重要性正在上升。该细分市场的特点是旨在确保针对年轻患者的药物管理安全性和有效性的创新。随着这两个细分市场的不断发展，它们反映了对不同患者人群中专业输注解决方案日益增长的需求。

### 按最终用户：医院（最大）与居家护理环境（增长最快）

在弹性体输注泵市场中，医院代表了最大的细分市场，由于对急性护理环境中可靠药物输送系统的高需求，享有显著的市场份额。家庭护理环境正在获得动力，因为它们迎合了越来越多偏好在家治疗的人群，导致该细分市场显著扩展。随着临床医生在门诊和长期护理中越来越多地采用弹性泵，市场份额的分布反映了医疗保健在各种环境中交付方式的持续演变。

医院（主导）与居家护理环境（新兴）

医院在弹性输注泵市场中占据主导地位，因为它们拥有为复杂药物方案提供服务的成熟基础设施，并且能够处理危重护理环境。这些设施受益于弹性泵的可靠性和精确性，从而提高了患者安全性和治疗效率。相比之下，家庭护理环境正在迅速崛起，越来越多的患者在家中接受治疗，这一趋势受到经济因素和患者对舒适与便利的偏好驱动。这一转变促进了对弹性泵使用的创新方法，使家庭护理成为一个日益具有竞争力的细分市场，符合个性化医疗的趋势。

### 按作用机制：持续输注（最大）与间歇性输注（增长最快）

弹性体输注泵市场在持续输注和间歇输注机制之间展示了显著的分布。持续输注仍然是最大的细分市场，因其便利性和能够提供恒定的药物输送速率，确保患者的稳定性而受到医疗专业人员的青睐。相比之下，间歇输注因其灵活性和能够满足特定患者需求的能力而迅速获得关注，在门诊护理环境中越来越受欢迎。

作用机制：持续输注（主导）与间歇输注（新兴）

持续输注的特点在于能够在较长时间内稳定地输送药物，主要用于需要一致性以确保患者结果的受控临床环境。这种方法允许精确给药，最小化药物水平的峰值和谷值风险。另一方面，间歇性输注作为一种灵活的替代方案显著崭露头角，特别是在门诊环境中受到青睐，因为它能够适应患者的日程安排和治疗方案。随着越来越多的医疗服务提供者认识到以患者为中心的护理的好处，这一领域正在获得发展，从而增强了药物依从性和治疗效果。

### 按产品型号：便携式输液泵（最大）与固定式输液泵（增长最快）

在弹性体输注泵市场中，便携式和固定式输注泵之间的市场份额分布显示出对便携式模型的明显偏好，便携式模型因其便利性和适应性而占据主导地位。便携式输注泵在临床环境中获得了显著的关注，使得患者管理更加灵活，提高了治疗效率。虽然固定式输注泵在市场份额上并不领先，但随着医疗机构对支持复杂疗法的基础设施的投资，其采用率正在增加。该细分市场的增长趋势主要受到技术进步和需要可靠输注疗法的患者数量增加的推动。便携式输注泵在居家护理环境中受到青睐，符合护理去中心化的趋势。同时，固定式输注泵在急性护理环境中变得至关重要，导致能力的融合，其中曾经仅限于便携式模型的功能正在被整合到固定系统中，以利用新兴市场需求。

产品型号：便携式输液泵（主导）与固定式输液泵（新兴）

便携式输液泵以其轻便的设计和用户友好的界面为特征，成为医疗服务提供者和患者的首选。它们在家庭护理环境中的日益使用突显了向以患者为中心的护理转变，在这种护理中，移动性和易用性至关重要。相比之下，传统上较为笨重的固定式输液泵正在通过整合先进功能来适应市场动态的变化，这些功能允许更好地监测和控制输液治疗。这项新兴技术展示了固定式泵在医疗环境不断演变和对复杂治疗方式需求增加的情况下，捕获更多市场份额的潜力。

## Regional Market Share Analysis

### 北美：创新的市场领导者

北美是弹性输注泵最大的市场，约占全球市场份额的45%。该地区的增长受到医疗支出增加、慢性疾病上升和医疗技术进步的推动。FDA等机构的监管支持进一步促进了市场扩展，确保医疗设备的安全性和有效性。美国是主要贡献者，巴克斯国际公司和ICU医疗公司等关键参与者主导着竞争格局。先进的医疗基础设施和以患者为中心的解决方案的关注促进了市场的增长。加拿大也发挥了重要作用，推动了对创新输注解决方案的需求。

### 欧洲：具有监管的新兴市场

欧洲是弹性输注泵的第二大市场，约占全球市场份额的30%。该地区的增长受到老龄化人口、慢性疾病的增加和确保高质量医疗产品的严格监管的推动。欧洲药品管理局（EMA）在监管医疗设备方面发挥了关键作用，促进创新的同时确保患者安全。德国和法国是该市场的领先国家，巴布朗梅尔松公司和费森尤斯卡比公司等公司贡献显著。竞争格局的特点是成熟企业和新兴初创企业的混合，专注于技术进步和改善患者结果。对居家医疗解决方案的重视也推动了该地区的需求。

### 亚太地区：快速增长与采用

亚太地区的弹性输注泵市场正在快速增长，约占全球市场份额的20%。该地区的扩展受到医疗投资增加、人口增长和对先进医疗技术认识提高的推动。中国和印度等国处于前沿，得到了政府旨在改善医疗基础设施和获取的支持。中国是该地区最大的市场，地方制造商和国际参与者如泰尔茂公司贡献显著。竞争格局正在演变，关注医疗解决方案的可负担性和可及性。慢性疾病的增加进一步推动了对弹性输注泵的需求，使该地区成为全球市场的关键参与者。

### 中东和非洲：医疗保健的未开发潜力

中东和非洲地区在弹性输注泵市场中逐渐崭露头角，约占全球市场份额的5%。增长受到医疗投资增加、慢性疾病的上升和改善医疗基础设施的关注的推动。各国政府正在实施政策以增强医疗获取，预计这将在未来几年推动市场增长。南非和阿联酋等国在市场中处于领先地位，国际参与者的存在日益增强。竞争格局的特点是本地和全球公司的混合，专注于针对该地区独特医疗挑战的创新解决方案。对优质医疗服务的需求增加可能会推动该地区弹性输注泵的采用。

## Competitive Benchmarking

弹性体输注泵市场目前的特点是动态竞争格局，受到对高效药物输送系统需求增加和对患者安全日益重视的驱动。主要参与者如巴克斯国际公司（美国）、B. Braun Melsungen AG（德国）和ICU医疗公司（美国）在战略上定位于利用创新和技术进步。巴克斯国际公司（美国）专注于通过持续的研究和开发来增强其产品组合，而B. Braun Melsungen AG（德国）则强调区域扩张和合作伙伴关系，以加强其市场存在。ICU医疗公司（美国）似乎专注于数字化转型举措，这些共同塑造了一个越来越依赖技术差异化和运营效率的竞争环境。

在商业策略方面，公司正在本地化生产，以减少交货时间并优化供应链，这在全球性干扰的背景下尤为重要。市场结构适度分散，多个参与者争夺市场份额，但主要公司的影响力仍然显著。这种竞争结构促进了一个创新和战略合作至关重要的环境，以维持竞争优势。

2025年8月，巴克斯国际公司（美国）宣布推出一款新的弹性体输注泵，旨在增强患者安全性并简化药物输送过程。这一战略举措可能会巩固巴克斯在市场上的领导地位，因为它满足了对先进输注技术日益增长的需求。这款产品的推出不仅展示了巴克斯对创新的承诺，还与行业向更复杂医疗设备的广泛趋势相一致。

2025年9月，B. Braun Melsungen AG（德国）与一家领先的远程医疗提供商达成战略合作伙伴关系，将远程监测功能整合到其弹性体输注泵中。这一合作表明了向数字健康解决方案的转变，增强了患者参与度和安全性。通过整合远程医疗功能，B. Braun可能会在竞争激烈的市场中区分其产品，吸引寻求综合解决方案的医疗服务提供者。

2025年7月，ICU医疗公司（美国）通过投资新设施扩大了其生产能力，专门用于生产弹性体输注泵。这项投资不仅旨在满足日益增长的需求，还反映了对供应链可靠性的战略关注。通过增强生产能力，ICU医疗公司正在为更有效地响应市场需求做好准备，从而加强其竞争地位。

截至2025年10月，弹性体输注泵市场的竞争趋势越来越受到数字化、可持续性和人工智能整合的定义。战略联盟变得越来越普遍，因为公司认识到协作创新的价值。竞争差异化可能会从传统的基于价格的竞争转向关注技术进步、产品可靠性和改善患者结果。这一转变强调了在应对当前市场复杂性时，创新和供应链韧性的重要性。

## Recent News & Developments

- **2024年第一季度：百特在欧洲推出下一代弹性输注泵市场** 百特国际宣布在获得CE标志批准后，在部分欧洲市场商业推出其新型弹性输注泵，旨在提高准确性和患者舒适度。
- **2024年第二季度：费森尤斯卡比获得FDA 510(k)清关，更新弹性输注泵市场** 费森尤斯卡比宣布已获得FDA 510(k)清关，允许其最新的弹性输注泵在美国的门诊和居家护理环境中扩展使用。
- **2024年第二季度：Leventon在西班牙扩大弹性输注泵的生产能力** Leventon S.A.U.在其巴塞罗那工厂启用了新的生产线，以满足欧洲和拉丁美洲对弹性输注泵日益增长的需求。
- **2024年第三季度：B. Braun在亚太市场推出Easypump II弹性输注泵** B. Braun宣布在亚太主要市场推出其Easypump II弹性输注泵，针对术后疼痛管理和化疗应用。
- **2024年第三季度：Ambu A/S任命新任输注设备部门负责人** Ambu A/S任命玛丽亚·詹森博士为其输注设备部门的新负责人，负责弹性输注泵产品的全球战略。
- **2024年第四季度：泰尔茂公司宣布与日本医院集团建立战略合作伙伴关系，供应弹性输注泵市场** 泰尔茂与一家领先的日本医院集团签署了多年供应协议，提供用于肿瘤学和疼痛管理治疗的弹性输注泵。
- **2024年第四季度：史密斯医疗获得加拿大卫生部批准，推出CADD®-Solis弹性输注泵市场** 史密斯医疗宣布获得加拿大卫生部对其CADD®-Solis弹性输注泵的批准，允许在加拿大进行商业分销。
- **2025年第一季度：百特与美国主要居家输注提供商签署分销协议** 百特与一家领先的美国居家输注提供商签署了分销协议，供应其用于慢性疾病管理的弹性输注泵。
- **2025年第一季度：Vygon集团推出儿童专用弹性输注泵市场** Vygon集团推出了一款专为儿童设计的弹性输注泵，旨在实现精确的低剂量药物输送，进入欧洲市场。
- **2025年第二季度：Nipro公司在越南开设新的弹性输注泵市场制造设施** Nipro公司在越南开设了一家新的弹性输注泵制造设施，旨在加强其在亚洲的供应链。
- **2025年第二季度：费森尤斯卡比与美国肿瘤网络合作，部署弹性输注泵市场** 费森尤斯卡比宣布与美国肿瘤网络建立合作关系，部署其用于门诊化疗治疗的弹性输注泵。
- **2025年第二季度：B. Braun获得下一代弹性输注泵市场的CE标志** B. Braun获得其下一代弹性输注泵的CE标志批准，允许在欧盟范围内扩大销售。

## Report Scope

| 2024年市场规模 | 3.276（十亿美元） |
| --- | --- |
| 2025年市场规模 | 3.428（十亿美元） |
| 2035年市场规模 | 5.391（十亿美元） |
| 复合年增长率（CAGR） | 4.63%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 十亿美元 |
| 主要公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 主要市场机会 | 智能技术的整合增强了弹性输注泵市场中的患者监测。 |
| 主要市场动态 | 对家庭医疗解决方案的需求上升推动了弹性输注泵市场的创新和竞争。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 到2035年，弹性体输注泵市场的预计市场估值是多少？**
A: 预计到2035年，弹性体输注泵市场的市场估值将达到53.91亿美元。

**Q: 2024年弹性体输注泵市场的市场估值是多少？**
A: 2024年弹性体输注泵市场的市场估值为32.76亿美元。

**Q: 在2025年至2035年的预测期内，弹性体输注泵市场的预期CAGR是多少？**
A: 在2025年至2035年的预测期内，弹性体输注泵市场的预期CAGR为4.63%。

**Q: 在弹性体输注泵市场中，哪些公司被视为关键参与者？**
A: 弹性体输注泵市场的主要参与者包括巴克斯国际公司、B. Braun Melsungen AG 和费森尤斯卡比公司。

**Q: 到2035年，弹性体输注泵在泵类型细分市场的预计收入是多少？**
A: 预计到2035年，弹性体输注泵在泵类型细分市场的收入将达到32.91亿美元。

**Q: 到2035年，弹性体输注泵的肿瘤学应用市场前景如何？**
A: 到2035年，弹性体输注泵在肿瘤学应用市场的预计将达到12亿美元。

**Q: 到2035年，作为弹性输注泵的最终用户，家庭护理设置的预期收入是多少？**
A: 预计到2035年，作为弹性体输注泵的最终用户，居家护理环境的预期收入将达到12.5亿美元。

**Q: 到2035年，弹性体输注泵市场中连续输注机制的预期收入是多少？**
A: 预计到2035年，弹性体输注泵市场中连续输注机制的预期收入将达到26.355亿美元。

**Q: 到2035年，便携式输液泵的预计收入是多少？**
A: 预计到2035年，便携式输液泵的收入将达到25亿美元。

**Q: 在弹性体输注泵市场中，疼痛管理应用的预期增长趋势是什么？**
A: 预计到2035年，弹性体输注泵市场中疼痛管理应用的预期收入将达到8亿美元。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/elastomeric-infusion-pump-market-32334*